Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $170.32 USD
Change Today -0.38 / -0.22%
Volume 598.2K
BCR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John H. Weiland

President, Chief Operating Officer and Director, CR Bard Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 3 different organizations across 3 different industries.

See Board Relationships
58$7,029,873
As of Fiscal Year 2014

Background*

Mr. John H. Weiland has been Vice President and Secretary of Rochester Medical Corporation since November 14, 2013. Mr. Weiland has been the President and Chief Operating Officer of the CR Bard Inc. since August 8, 2003. Mr. Weiland served as the Group President of Davol, Urological, Medical and Endoscopic Technology at CR Bard Inc. since 1997 until August 2003 , where he has responsibility for all Bard's businesses in Japan, Latin and Central America, Canada and Asia ...

Read Full Background

Corporate Headquarters*

730 Central Avenue
Murray Hill, New Jersey 07974

United States

Phone: 908-277-8000
Fax: 908-277-8412

Board Members Memberships*

1986-N/A
Former Director
2005-Present
President, Chief Operating Officer and Director
2007-Present
Director and Chairman of Compensation Committee
2013-Present
Vice President, Secretary and Director

Education*

MBA
New York University
BS
DeSales University

Other Affiliations*

Annual Compensation*

Salary$887,000
Total Annual Compensation$887,000

Stock Options*

Restricted Stock Awards$2,398,137
All Other Compensation$1,011,689
Exercised Options194,124
Exercised Options Value$10,512,916
Exercisable Options33,524
Exercisable Options Value$1,879,833
Unexercisable Options101,427
Unexercisable Options Value$3,669,166
Total Value of Options$16,061,914
Total Number of Options329,075

Total Compensation*

Total Annual Cash Compensation$2,954,219
Total Short Term Compensation$887,000
Other Long Term Compensation$3,409,826
Total Calculated Compensation$7,029,873
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $170.32 USD -0.38

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Olivier A. Filliol Chief Executive Officer, President and Director
Mettler-Toledo International Inc.
$965.2K
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
$900.0K
Lukas Braunschweiler Chief Executive Officer and Member of Management Board
Sonova Holding AG
SFr.1.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.